Vericel
Markets patient-specific cell therapies for knee-cartilage repair and severe burns, plus enzymatic burn debridement.
$40.95
After-hours close0.00 (0.00%)
At close$40.95(−0.56%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 114.23%Insiders 1.19%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 51.21M · Float 50.58M · 98.8% free float
Institutions13F, as of Jun 30, 2026
323 holders · 58.49M shares · 66 new positions · 188 increased · 99 reduced · 27 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 8.09M | 15.80% | +326.9K | Aug 7, 2026 |
| State Street Corp | 3.29M | 6.43% | +141.8K | Aug 7, 2026 |
| Congress Asset Management Co /MA | 2.92M | 5.70% | +1.41M | Jul 7, 2026 |
| Vanguard Capital Management LLC | 2.26M | 4.41% | +25.0K | Aug 13, 2026 |
| Conestoga Capital Advisors, LLC | 2.08M | 4.07% | −379.5K | Jul 24, 2026 |
| William Blair Investment Management, LLC | 1.99M | 3.89% | +160.1K | Aug 12, 2026 |
| BNP Paribas Asset Management Holding S.A. | 1.64M | 3.20% | −83.6K | Aug 13, 2026 |
| GW&K Investment Management, LLC | 1.55M | 3.03% | −66.4K | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 15.10% | 7.57M | 13G | Apr 30, 2025 ↗ |
| State Street Corporation | 5.60% | 2.81M | 13G | Nov 10, 2025 ↗ |
| Vanguard Capital Management | 5.11% | 2.60M | 13G | Apr 30, 2026 ↗ |
| Soleus Capital Master Fund, L.P. | 5.00% | 2.55M | 13G | Apr 1, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Dominick Colangelo | director, officer: President and CEO | 312.4K | 0.61% | Feb 26, 2026 |
| Jonathan Mark Hopper | officer: Chief Medical Officer | 75.8K | 0.15% | Jun 30, 2026 |
| Alan L. Rubino | director | 64.2K | 0.13% | May 1, 2026 |
| Heidi Hagen | director | 35.1K | 0.07% | May 1, 2026 |
| Robert L. Md Zerbe | director | 33.0K | 0.06% | May 1, 2026 |
| Paul K. Wotton | director | 18.8K | 0.04% | May 13, 2026 |
| Kevin F. Mclaughlin | director | 18.3K | 0.04% | Aug 14, 2026 |
| Michael Halpin | officer: Chief Operating Officer | 16.4K | 0.03% | Aug 5, 2026 |
| Joseph Anthony Jr Mara | officer: Chief Financial Officer | 16.0K | 0.03% | Jun 30, 2026 |
| Lisa Wright | director | 15.9K | 0.03% | May 1, 2026 |
3 ten-percent owners hold 3.02M shares by Form 4, outside the officers-and-directors figure above · 18 people have not refiled in the last 18 months (251.0K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 12, 2026 | Kevin F. Mclaughlindirector | Sale | 7,000 | $44.53 | 18,300 |
| Aug 3, 2026 | Michael Halpinofficer: Chief Operating Officer | Sale | 10,000 | $46.84 | 16,394 |
| Jul 30, 2026 | Jonathan Siegalofficer: Principal Accounting Officer | Sale | 500 | $48.90 | 1,078 |
| Jun 26, 2026 | Sean C. Flynnofficer: Chief Legal Officer | Sale | 15,000 | $45.64 | 1,647 |
| Jun 26, 2026 | Jonathan Mark Hopperofficer: Chief Medical Officer | Sale | 5,000 | $45.00 | 75,753 |
| Jun 26, 2026 | Joseph Anthony Jr Maraofficer: Chief Financial Officer | Sale | 5,000 | $44.75 | 16,009 |
| Jun 26, 2026 | Jonathan Siegalofficer: Principal Accounting Officer | Sale | 2,500 | $44.90 | 886 |
| Jun 18, 2026 | Sean C. Flynnofficer: Chief Legal Officer | Sale | 15,000 | $40.21 | 1,647 |
| Jun 18, 2026 | Michael Halpinofficer: Chief Operating Officer | Sale | 10,000 | $40.24 | 16,248 |
| Jun 2, 2026 | Jonathan Mark Hopperofficer: Chief Medical Officer | Sale | 4,375 | $35.00 | 75,753 |
CongressHouse and Senate disclosures
Not reported.